Besides, HO-1 expression decreased in immune cells from systemic sclerosis (SSc) patients, whereas Co-PPIX treatment could restore HO-1 levels in DCs and normalize the increased TLR response observed in SSc (van Bon et al., 2016). This evidence concerns the gene HMOX1 and systemic sclerosis.